TAMPA, Fla., July 12, 2004 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC) announced today that the Company, in conjunction with Third World Technology Inc., has expanded its technology infrastructure thus enabling it to become the premier facilitator of low-cost prescription medications in the United States. Additionally, the Company is pleased to announce that it has retained Third World Technology Inc. on an ongoing consultancy basis.
Third World Technology Inc. has recently completed a new website for Rx Processing Corp., www.rxprocessingcorp.com, and revamped the Company's technology infrastructure to include www.mycanadadrugs.com, the affiliate system, and analysis and procedural documentation for implementation of Canada Drugs of Spring Hills' technologies upon the closure of the recently announced merger. With these tasks accomplished, Third World Technology will continue to work with Rx Processing to continue the rapid expansion of the Company's technologies and capabilities providing a secure and safe ordering and information source for prescription medications.
Tim Gillesse President and Chief Executing Officer of Third World Technology Inc., stated, "Rx Processing's mission is to enable all U.S citizens safe and affordable prescription medications. With our help, we have enabled them to have the most expansive and secure distribution channel in the industry. I applaud Rx Processing's willingness to provide access to these low-cost prescriptions to U.S. citizens."
Peter Fiorillo said in response, "We are pleased to have partners as supportive as Third World Technology. We are excited to know that our infrastructure is years beyond others in the industry and is built to handle the expanding order flow that will develop as more people become aware of their ability to safely order low-cost prescription medications."
About Rx Processing Corporation
Rx Processing is in the business of providing U.S. citizens with access to low-cost Canadian prescription pharmaceuticals. Current international pricing controls regulate the prices pharmaceutical companies can charge in their local market. The Company, using the safety measures of U.S. Government's Meds Act of 2000, provides U.S. citizens with access to these low-cost prescription drugs. Utilizing Rx Processing, U.S. citizens can save 25% - 84% on their daily prescriptions. These reduced cost medications are available at the Company's affiliate retail storefronts and through the website at www.mycanadadrugs.com.
The Company encourages its shareholders and all concerned parties to call their senators and urge them to pass the Dorgan-Snowe prescription drug importation bill. Call 800-795-5336
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.